As a sensitive marker of acute phase proteins and inflammatory responses in vivo, C-reactive protein (CRP) can effectively compensate for the negative results of partial RF screening in the diagnosis of autoimmune diseases, which could effectively avoid the occurrence of misdiagnosis and missed diagnosis [65, 66]. This evidence concerns the gene CRP and autoimmune disease.